← FDA DRUG APPROVALS

FDA NDA · NDA006799

RUBRAMIN PC

Sponsor: BRISTOL MYERS SQUIBB

APPLICATION
NDA006799
TYPE
NDA
ORIGINAL APPROVAL
1950-09-29
LATEST ACTION
2007-12-07
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

RUBRAMIN PC · ReferenceDiscontinued
CYANOCOBALAMIN 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION
RUBRAMIN PC · ReferenceDiscontinued
CYANOCOBALAMIN 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION
RUBRAMIN PCDiscontinued
CYANOCOBALAMIN 0.1MG/ML · INJECTABLE · INJECTION

Approval history

2007-12-07Labeling · Supplement 14AP
2007-12-07Labeling · Supplement 4AP
1995-11-28Labeling · Supplement 15 · standardAP
1987-10-14Manufacturing (CMC) · Supplement 13 · standardAP
1986-05-05Manufacturing (CMC) · Supplement 12 · standardAP
1985-07-31Manufacturing (CMC) · Supplement 9 · standardAP
1984-10-01Labeling · Supplement 11AP
1984-07-09Labeling · Supplement 10AP
1983-12-15Labeling · Supplement 8AP
1980-08-26Labeling · Supplement 7AP
1979-01-19Labeling · Supplement 6AP
1950-09-29Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →